Carbiotix

Carbiotix is a pre-clinical stage therapeutics company based in Sweden, focusing on gut health testing and microbiome modulators to tackle various chronic and metabolic diseases. Founded in 2014, the company emerged from four years of research at Lund University and the Antidiabetic Food Centre. Carbiotix developed a low-cost gut health testing platform, which was launched in 2018 alongside a significant 600-person gut health study. The company’s innovative products include OneGut, MonthGut, LinkGut, and HealthGut, all designed to leverage proprietary soluble fibers and isolated strains. Carbiotix aims to harness the potential of the gut microbiome to improve health outcomes and advance therapeutic development.